You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thyroid Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Deposits for Patients With Papillary Thyroid Carcinoma

Completed
  • Exploring the Prognostic Value of Tumor Deposits PTC Patients
  • surgery
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Sep 18, 2023

Thyroid Tumor Trial (Improved intubation process, Conventional intubation process, Early resumption of oral intake)

Not yet recruiting
  • Thyroid Tumor
  • Improved intubation process
  • +3 more
  • (no location specified)
Nov 20, 2022

Clinical Application of Sonozoid in Thyroid Tumor

Completed
  • Ultrasound
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Aug 7, 2021

    Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

    Recruiting
    • Benign Thyroid Gland Neoplasm
    • +4 more
    • Quality-of-Life Assessment
    • Radiofrequency Ablation
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 3, 2022

    Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

    Recruiting
    • Thyroid Cancer
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 19, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

    Recruiting
    • Bone Sarcoma
    • +15 more
    • Aldesleukin
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Eastern Ablation Registry for Solid Tumor (EAST)

    Recruiting
    • Solid Tumor Including Thyroid, Bone, Liver, Pancreas
    • RFA, MWA, cryo and IRE
    • Taipei, Taiwan
      National Taiwan University Hospital
    Oct 11, 2022

    Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

    Not yet recruiting
    • Adrenal Cortical Carcinoma
    • +3 more
    • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
    • Shanghai, Shanghai, China
      Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
    Nov 19, 2023

    Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

    Recruiting
    • Thyroid Cancer, Medullary
    • +3 more
    • Basel, Switzerland
      University Hospital Basel, Clinic for radiology and nuclear medi
    May 23, 2022

    Predictive MRI Metrics for Tumor Aggressiveness in Papillary

    Completed
    • Papillary Thyroid Cancer
    • diffusion weighted (DW) MRI
    • dynamic contrast agent (DCE) MRI
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 6, 2021

    Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

    Recruiting
    • Medullary Thyroid Cancer
    • Anlotinib Hydrochloride Capsule
    • Hefei, Anhui, China
    • +18 more
    Apr 14, 2023

    Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

    Not yet recruiting
    • Cancer
    • +5 more
    • (no location specified)
    Aug 18, 2022

    Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

    Active, not recruiting
    Has Results
    • Solid Tumor
    • Medullary Thyroid Cancer
    • Guangzhou, Guangdong, China
    • +12 more
    May 9, 2022

    Medullary Thyroid Carcinoma Trial in China (HA121-28 tablets)

    Recruiting
    • Medullary Thyroid Carcinoma
    • HA121-28 tablets
    • Beijing, Beijing, China
    • +12 more
    Feb 7, 2022

    Advanced Solid Tumor Trial (HEC169096)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Jul 6, 2022

    Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

    Recruiting
    • Advanced Solid Tumor
    • +8 more
    • CNSI-Fe(II) 30 mg
    • +2 more
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Sep 15, 2023

    Endocrine Tumor Trial in Vandœuvre-lès-Nancy

    Recruiting
    • Endocrine Tumor
      • Vandœuvre-lès-Nancy, France
        CHU Nancy
      Mar 8, 2022

      Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

      Recruiting
      • Cancer
      • +18 more
      • Houston, Texas
        MD Anderson Cancer Center
      Aug 12, 2022

      NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Shanghai, Shanghai, China
      • +1 more
      Mar 17, 2022

      Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

      Recruiting
      • Advanced Cancer
      • +24 more
      • pembrolizumab
      • Los Angeles, California
      • +21 more
      Jan 18, 2023

      Circulating Biomarkers to Identify Thyroid Cancer

      Completed
      • Thyroid Cancer
      • +2 more
      • Identification group
      • Validation group
      • Kaohsiung, Taiwan
        Kaohsiung Chang Gung Memorial Hospital
      Oct 16, 2020

      Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

      Recruiting
      • Solid Tumor
      • +11 more
      • Belfast, United Kingdom
      • +16 more
      Mar 2, 2023

      International PPB/DICER1 Registry

      Recruiting
      • Pleuropulmonary Blastoma
      • +14 more
        • Minneapolis, Minnesota
          Children's Minnesota
        Aug 16, 2022

        Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

        Recruiting
        • Solid Tumor
        • +8 more
        • Los Angeles, California
        • +5 more
        Jun 27, 2022